Takeda Pharmaceutical Q1 Adj. EPADS $0.52 Beats $0.47 Estimate, Sales $7.66B Beat $7.53B Estimate

Author: Benzinga Newsdesk | July 30, 2025 02:43am
Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.47 by 11.06 percent. This is a 6.79 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $7.66 billion which beat the analyst consensus estimate of $7.53 billion by 1.68 percent. This is a 1.24 percent decrease over sales of $7.75 billion the same period last year.

Posted In: TAK